Coventry University Featured PhD Programmes
National University of Ireland, Galway Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Exeter Featured PhD Programmes
University College London Featured PhD Programmes
"systems" AND "engineerin…×
10 miles

Pharmacy / Pharmaceutics (systems engineering) PhD Projects, Programs & Scholarships

We have 16 Pharmacy / Pharmaceutics (systems engineering) PhD Projects, Programs & Scholarships

  • "systems" AND "engineering" ×
  • Pharmacy / Pharmaceutics×
  • clear all
Order by 
Showing 1 to 10 of 16
  Bioactive Scaffolds for Tissue Engineering and Regenerative Medicine
  Dr P De Bank
Applications accepted all year round

Funding Type

PhD Type

Tissue engineering and regenerative medicine aim to either replace diseased or damaged tissue with a functional, laboratory-grown substitute, or stimulate the body’s own cells in order to promote repair.
  Predictive modelling and design optimisation of erodible drug delivery systems
  Prof R Wildman
Applications accepted all year round

Funding Type

PhD Type

3 year PhD Studentship in Enabling Next Generation Additive Manufacturing. Title. Predictive modelling and design optimisation of erodible drug delivery systems.
  Novel drug delivery systems for Schizophrenia treatment
  Dr E Larraneta
Applications accepted all year round

Funding Type

PhD Type

This PhD project aims to develop, characterise and test a new type of implantable device to provide sustained antipsychotic drug delivery for schizophrenia treatment.
  Phd Studentship Opportunity in a combined experimental and numerical study of powder flow during pharmaceutical manufacturing
  Prof C Wu
Applications accepted all year round

Funding Type

PhD Type

We are looking for a talented candidate to work on a PhD project in collaboration with a pharmaceutical company based in San Francisco, California, USA.
  Pharmacoengineering of advanced RNA-nanomedicines to treat cystic fibrosis (CF)
  Prof S Cryan, Prof A Heise, Prof C Greene
Applications accepted all year round

Funding Type

PhD Type

Cystic fibrosis (CF) is an inherited disorder caused by a mutation in a single gene responsible for the production of a protein called the cystic fibrosis transmembrane conductance regulator (CFTR).
  Oral delivery of insulin for diabetes therapy: Development and evaluation of insulin loaded polymer/lipid based carrier systems
  Dr A Vangala
Applications accepted all year round

Funding Type

PhD Type

Diabetes is a chronic metabolic disorder that affects nearly 500 million people worldwide. Its hallmark feature, hyperglycaemia is caused due to insulin deficiency and/or resistance.
  Nano-engineered Delivery Systems for the Targeted Delivery of Oncology Drugs for Non-Small Cell Lung Cancer
  Dr H McCarthy, Dr N Buckley
Applications accepted all year round

Funding Type

PhD Type

Lung cancer is the most common cancer worldwide accounting for 11.6% of the global burden. The standard of care (SoC) chemotherapy typically involves a ‘cocktail’ of drugs which confer debilitating side-effects, resulting in sub-optimal dosing with a reduced clinical efficacy.
  Centre for Doctoral Training (CDT) in Sustainable Production of Chemicals and Materials

Funding Type

PhD Type

The University of Aberdeen has been awarded over £1million in funding to establish a centre that will train a new generation of researchers to develop technologies that convert organic waste into sustainable materials.
  Carbon Nanotubes Mediated Drug Delivery in 3D cancer models
  Dr H Ali-Boucetta
Applications accepted all year round

Funding Type

PhD Type

Current treatment with anticancer drugs suffers from the drawbacks of systemic toxicity, drug resistance and limited cellular entry.
  Designing novel composite polysaccharide nanoparticles for combined diagnosis and treatment of cancers
  Dr E Barbu, Dr A Lalatsa
Applications accepted all year round

Funding Type

PhD Type

Cancer continues to impose a vast burden with regard to financial costs as well as human suffering but the progress in its treatment is hindered by the limited selectivity and significant side-effects that the current chemotherapy demonstrates, representing a major challenge for modern drug delivery.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2020
All rights reserved.